How is COVID-19 impacting pharmaceutical manufacturers and biotech's?

The aim of this survey is to understand the impact that the current COVID-19 pandemic is having on pricing, reimbursement and market access for pharmaceutical manufacturers and biotech's.

We would very much appreciate it if you could spare 2-3 minutes to complete the survey by end of business 18/04/2020.

At the end of this survey, if you provide your email address we would be delighted to share with you the results of the survey.

Question Title

* 1. What impact is COVID-19 having on your company today?

No impact

Low impact

Medium impact

Significant impact

N/A

No impact

Low impact

Medium impact

Significant impact

N/A

Question Title

* 2. For your existing products, what impact has COVID-19 had on …

	No impact	Low impact	Medium impact	Significant impact	N/A
Price?	Price? No impact	Price? Low impact	Price? Medium impact	Price? Significant impact	Price? N/A
Please explain
Market Access?	Market Access? No impact	Market Access? Low impact	Market Access? Medium impact	Market Access? Significant impact	Market Access? N/A
Please explain
Uptake?	Uptake? No impact	Uptake? Low impact	Uptake? Medium impact	Uptake? Significant impact	Uptake? N/A
Please explain

Question Title

* 3. What impact has COVID-19 had on your new pipeline products?

	No impact	Low impact	Medium impact	Significant impact	N/A
Clinical trials/evidence generation programs?	Clinical trials/evidence generation programs? No impact	Clinical trials/evidence generation programs? Low impact	Clinical trials/evidence generation programs? Medium impact	Clinical trials/evidence generation programs? Significant impact	Clinical trials/evidence generation programs? N/A
Please explain
Ongoing pricing and market access projects?	Ongoing pricing and market access projects? No impact	Ongoing pricing and market access projects? Low impact	Ongoing pricing and market access projects? Medium impact	Ongoing pricing and market access projects? Significant impact	Ongoing pricing and market access projects? N/A
Please explain
Ability to begin/initiate new pricing and market access projects?	Ability to begin/initiate new pricing and market access projects? No impact	Ability to begin/initiate new pricing and market access projects? Low impact	Ability to begin/initiate new pricing and market access projects? Medium impact	Ability to begin/initiate new pricing and market access projects? Significant impact	Ability to begin/initiate new pricing and market access projects? N/A
Please explain
Time to market?	Time to market? No impact	Time to market? Low impact	Time to market? Medium impact	Time to market? Significant impact	Time to market? N/A
Please explain
Other?	Other? No impact	Other? Low impact	Other? Medium impact	Other? Significant impact	Other? N/A
Please explain
N/A	N/A No impact	N/A Low impact	N/A Medium impact	N/A Significant impact	N/A N/A
Please explain

Question Title

* 4. If your pipeline products are delayed due to COVID-19, by approximately how many months do you anticipate the delay?

Unsure

Less than 3 months?

3-6 months?

6-12 months?

More than 12 months?

Question Title

* 5. If your pipeline products are delayed due to COVID-19, please state what the delays have been?

Question Title

* 6. If you have products currently undergoing national P&R/HTA assessment in the EU, what impact has COVID-19 had?

No impact

Low impact

Medium impact

Significant impact

N/A

No impact

Low impact

Medium impact

Significant impact

N/A

Question Title

* 7. What impact has COVID-19 had on your pricing and market access department/team?

No impact

Low impact

Medium impact

Significant impact

N/A

No impact

Low impact

Medium impact

Significant impact

N/A

Question Title

* 8. What do you see as your major challenge for the business resulting from COVID-19, if any?

Short term

Long term

Question Title

* 9. What impact do you think COVID-19 will have on the future payer/HTA and pricing landscape in the EU in the next 1-3 years?

	No impact	Low impact	Medium impact	Significant impact	N/A
Price?	Price? No impact	Price? Low impact	Price? Medium impact	Price? Significant impact	Price? N/A
Please explain
National market access/HTA assessments?	National market access/HTA assessments? No impact	National market access/HTA assessments? Low impact	National market access/HTA assessments? Medium impact	National market access/HTA assessments? Significant impact	National market access/HTA assessments? N/A
Please explain
Regional/local market access?	Regional/local market access? No impact	Regional/local market access? Low impact	Regional/local market access? Medium impact	Regional/local market access? Significant impact	Regional/local market access? N/A
Please explain

How is COVID-19 impacting pharmaceutical manufacturers and biotech's?

Question Title

* 1. What impact is COVID-19 having on your company today?

Question Title

* 2. For your existing products, what impact has COVID-19 had on …

Question Title

* 3. What impact has COVID-19 had on your new pipeline products?

Question Title

* 4. If your pipeline products are delayed due to COVID-19, by approximately how many months do you anticipate the delay?

Question Title

* 5. If your pipeline products are delayed due to COVID-19, please state what the delays have been?

Question Title

* 6. If you have products currently undergoing national P&R/HTA assessment in the EU, what impact has COVID-19 had?

Question Title

* 7. What impact has COVID-19 had on your pricing and market access department/team?

Question Title

* 8. What do you see as your major challenge for the business resulting from COVID-19, if any?

Question Title

* 9. What impact do you think COVID-19 will have on the future payer/HTA and pricing landscape in the EU in the next 1-3 years?

Question Title

* 10. What are the reasons why you expect these changes to the PMA landscape?

Question Title

* 11. Please use this comment box to raise other COVID-19-related topics that you'd like us to be aware of.

Question Title

* 12. Please provide your email address if you would like us to share the results of the survey with you